Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
All About Inc, 10 times Increase in Ordinary Profit for The Current Fiscal Year
2454 All About,Inc. 【J-GAAP】
Earnings ReportAll About,Inc. <2454> [TSE Std] announced its financial results after the market closed on May 12th (16:30). The consolidated ordinary profit/loss for the fiscal year ending March 2025 turned into a profit of 10 million yen (compared to a loss of 438 million yen in the previous period). For the fiscal year ending March 2026, the consolidated ordinary profit is expected to surge 10 times the previous term, reaching 100 million yen.
At the same time, the company decided to implement a year-end dividend of 3 yen for the previous term, which had been previously undecided, and has left the annual dividend for the current term undetermined.
In the most recent three-month period, from January to March (4Q), the consolidated ordinary profit/loss turned to a profit of 179 million yen (compared to a loss of 66 million yen in the same period last year). The operating profit/loss margin drastically improved from -1.6% in the same period last year to 4.2%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2023 | 16,917 | 6 | 20 | -82 | -6.1 | 3 | May 10, 2023 | J-GAAP |
| Mar, 2024 | 15,703 | -461 | -438 | -456 | -33.0 | 3 | May 10, 2024 | J-GAAP |
| Mar, 2025 | 15,954 | 10 | 10 | -39 | -2.8 | 3 | May 12, 2025 | J-GAAP |
| YoY | +1.6% | - | - | +91.4% | +91.5% |
Full Year Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2025 Guidance | 16,500 | 0 | 0 | -80 | -5.7 | - | May 10, 2024 | J-GAAP |
| Mar, 2025 Results | 15,954 | 10 | 10 | -39 | -2.8 | 3 | May 12, 2025 | J-GAAP |
| Revision Rate | -3.3% | - | - | +51.2% | +51.0% |
Current Period Guidance
H1 Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Sep, 2024 | 7,451 | -199 | -199 | -157 | -11.3 | 0 | Nov 12, 2024 | J-GAAP |
| Apr - Sep, 2025 Guidance | 7,900 | -185 | -185 | -160 | -11.4 | 0 | May 12, 2025 | J-GAAP |
| YoY | +6.0% | +7.0% | +7.0% | -1.9% | -0.2% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2024 | 15,703 | -461 | -438 | -456 | -33.0 | 3 | May 10, 2024 | J-GAAP |
| Mar, 2025 | 15,954 | 10 | 10 | -39 | -2.8 | 3 | May 12, 2025 | J-GAAP |
| Mar, 2026 Guidance | 16,700 | 100 | 100 | 0 | 0.0 | - | May 12, 2025 | J-GAAP |
| YoY | +4.7% | +900.0% | +900.0% | - | - |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Mar, 2024 | 4,027 | -65 | -66 | -198 | -14.3 | -1.6 | May 10, 2024 | J-GAAP |
| Apr - Jun, 2024 | 3,668 | -171 | -166 | -122 | -8.8 | -4.7 | Aug 8, 2024 | J-GAAP |
| Jul - Sep, 2024 | 3,783 | -28 | -33 | -35 | -2.5 | -0.7 | Nov 12, 2024 | J-GAAP |
| Oct - Dec, 2024 | 4,194 | 27 | 30 | 5 | 0.4 | 0.6 | Feb 10, 2025 | J-GAAP |
| Jan - Mar, 2025 | 4,309 | 182 | 179 | 113 | 8.1 | 4.2 | May 12, 2025 | J-GAAP |
| YoY | +7.0% | - | - | - | - |
Related Articles
NANYO, 7% Decrease in Ordinary Profit for The Current Fiscal Year, Despite Last Fiscal Year's Dividend Increase, This Fiscal Year to Decrease Dividend
Noile-Immune Biotech, Jan-Mar (1Q) Ordinary Profit Loss Narrows
Sockets, Net Income/Loss Unexpectedly Turn to Loss for Last Fiscal Year, Returning to Profitability This Year
KENKO Mayonnaise, 1% Decrease in Ordinary Profit for The Current Fiscal Year, Increased Previous Year's Dividend by 5 yen, This Fiscal Year to Increase Dividend by 4 yen
PIXTA, Jan-Mar (1Q) Ordinary Profit Decreases by 36%
TOKYO ENERGY & SYSTEMS, 23% Increase in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 5 yen
SENKO, 13% Increase in Ordinary Profit, Update Record High for Fifteenth Consecutive Term, Dividend Raised by 4 yen
FUJI JAPAN, Jan-Mar (1Q) Ordinary Profit Turns to Loss
KOZO KEIKAKU ENGINEERING, Jul-Mar (Cumulative 3Q) Ordinary Profit Increases by 32%, Jan-Mar Ordinary Profit Increases by 6%
SEIKITOKYU KOGYO, 2% Decrease in Ordinary Profit for The Current Fiscal Year, Dividend to Cut by 20 yen